AQP3 and xerostomia: Additionally, it has been suggested that AQP-3 and AQP-5 expression as well as the degree of immunoreactivity in the labial salivary glands could be used to differentiate between people who are systemically healthy from those who have objective and subjective xerostomia, or Sjögren’s syndrome.